
XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd. (XTLB) Number of Employees – History & Annual Headcount
Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.
SEC EDGAR · FMP · XTLB · as of Apr 30, 2025
Latest filing snapshot
XTL Biopharmaceuticals Ltd. (XTLB) employee data is sourced from the annual SEC 20-F filing. As of 2024, full-time employees only. Global consolidated headcount. View SEC filing ↗
XTLB Employee Count
2005 – 2024 · Annual · SEC filingSource: SEC annual filings · Hover bar to view year data · Click to view original filing
Employees History
▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.
Related Companies — Employee Count
BiotechnologyAbout XTLB employees
XTLB Employees · Headcount
XTL Biopharmaceuticals Ltd. (XTLB) employee data is sourced from the annual SEC 20-F filing. As of 2024, XTL Biopharmaceuticals Ltd. had 10 full-time employees globally. Full-time employees only. Global consolidated headcount.
XTL Biopharmaceuticals Ltd. employs 10 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $45,100, reflecting the company's operational efficiency.
XTL Biopharmaceuticals Ltd.'s workforce increased by 9 (900.00%) in 2024 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.
XTL Biopharmaceuticals Ltd.'s revenue per employee of $45,100 positions it among the notable performers in the Biotechnology sector for operational efficiency.
Frequently Asked Questions
XTLB Employees · 5 questionsAs of the latest SEC 20-F filing (2024), XTL Biopharmaceuticals Ltd. had 10 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.
▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-04-30